Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

The Bellcast

The Bellcast
Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1
Feb 23, 2023
Bell Direct

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara's journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
- (0:59) Becoming a Bell Potter Analyst
- (2:56) Approaches to analysing a company
- (7:18) Orthocell's global 25-year exclusive agreement
- (7:53) Orthocell's TGA approval for its Remplir device
- (8:44) Orthocell's speculative buy rating

Note: This interview was filmed on 7 February 2023.